Biogenic synthesis of ZnO and Al2O3 nanoparticles using Camellia sinensis and Origanum vulgare L. leaves extract for spectroscopic estimation of ofloxacin and ciprofloxacin in commercial formulations

The current study describes the biogenic synthesis of two metal oxides zinc oxide (ZnO), aluminum oxide (Al2O3) nanoparticles using Camellia sinensis, and Origanum vulgare L. leaves extract, respectively. The synthesized metal oxide nanoparticles were investigated using spectroscopic and microscopic techniques to confirm the formation of their nanostructures. Accurate and precise spectrofluorometric probes were proposed for the quantification of Ofloxacin (OFX) and Ciprofloxacin (CPFX) in their bulk and commercial formulations. The extraordinary properties of Zinc oxide and aluminum oxide nanoparticles (ZnONPs and Al2O3NPs) enhance the fluorescence intensity in the presence of 0.5 mL and 1.0 mL of sodium dodecyl sulfate (SDS, 1.0% w/v) as organizing agent for the detection of OFX and CPFX, respectively. The optical detection of both drugs at λex/em range 250–700 nm displayed linearity with a main correlation coefficient >0.999 at 1–300 (OFX-SDS-ZnONPs) and 0.5–100 (OFX-SDS-Al2O3NPs) ng mL-1,10–400 (CPFX-SDS-ZnONPs) and 0.1–50 (CPFX-SDS-Al2O3NPs) ng mL-1. The detection and quantification limits were found to be 0.04, 0.03, and 0.02, 0.04 ng mL-1, 0.13, 0.10, and 7.24, 0.09 ng mL-1 for the above-mentioned fluorescence systems, respectively. The suggested spectrofluorometric probes were validated and potentially applied for the estimation of OFX and CPFX in their bulk and commercial formulations.


Introduction
Microbial infections are important human diseases caused by a variety of microorganisms such as viruses, parasites, fungi, and bacteria [1].These diseases can be transmitted to humans or animals through direct or indirect contact with the source of infection [2].Unsuitable or unregulated pharmaceutical doses are one of the main causes of death worldwide, particularly among children and young people [3].Antibacterial drugs have recently been utilized to reduce or kill the growth of a variety of Gram-positive and Gram-negative infections [4].The broad-spectrum antibacterial fluoroquinolones pharmaceuticals are among these antibiotics, and they are commonly used for a variety of hospital and community-acquired illnesses [5].
Despite the fact that these previously stated separation techniques have excellent selectivity and sensitivity, they require expensive apparatus, highly skilled analysts, complex preconditions, and lengthy procedures.As a result, they still have some restrictions.Furthermore, electrochemical procedures are rapid to perform; the recorded data is obtained as electrical impulses; yet, these techniques have a history of analytical errors, necessitating environmental protection to reduce toxicity.A fluorescence approach for detecting a specific wavelength has the advantages of simplicity, high sensitivity, non-destruction, and susceptibility to background interferences compared to other analytical techniques [16][17][18].
With advancements in all domains of technology and industry, new nanoscale materials with distinct chemical and physical properties have been discovered [19,20].To improve the sensitivity of the analytical detection of various sensing probes, nanomaterials such as noble metals, quantum dots, nanocomposites, and nanometal oxides have been used as alternatives to standard fluorophores [21][22][23][24].To increase the fluorescence intensity, nanostructures have also been used as sensor substrates.Recent studies have shown that it is possible to boost the fluorescence of affordable and non-toxic nanometal oxides, which holds tremendous promise for biomedical applications [25].
Metal oxides, which have visual properties, good chemical reactivity, outstanding electrical conductivity, and potential catalytic and chemical reactivity, are among the nanomaterials that can be made in an environmentally acceptable manner [26].Because of their exceptional physicochemical properties, zinc oxide (ZnONPs) and aluminum oxide (Al 2 O 3 NPs) nanostructures have recently attracted a lot of attention.Thin films, quantum dots, nanoflowers, and nanorods are all examples of ZnO nanostructures that are widely used as major semiconducting materials for various sensing and biosensing applications [27,28].At room temperature, these ZnO nanostructures are optically stable, with a large band gap (3.36 eV) and significant exciton energy (60 meV).Furthermore, ZnO nanostructures absorb UV rays and hence serve as effective signal enhancers for FL-based sensors [29], sensors and biosensors [30][31][32][33], food additives [34], electronic systems [35], industrial productions [36], catalysis [37], and medication delivery systems [38] are only a few of the new applications for these nanoparticles.The most fascinating metal oxides with unique features are aluminum oxide or alumina (Al 2 O 3 ) nanoparticles.Over a large temperature range, they are thermodynamically stable particles.Surface charge, shape, and particle size all influence the behavior of alumina nanoparticles.They're also employed in fluorescence-based biosensors [39], electrochemical sensors [40-43], clinical applications [44], and biomedical applications [45].
The literature survey addressed many reports concerned with different developed methods for ZnO and Al 2 O 3 nanoparticles synthesis including co-precipitation [46, 47], sol-gel [48, 49], microwave-assisted methods [50,51], and thermal decomposition [52,53].The size and shape of the nanostructured metal oxides can be changed by varying the synthesis conditions used.However, certain drawbacks such as bioaccumulation, loss of mechanism understanding, high toxicity, the natural damage accompanied by the elevation of toxic materials, wastes generated during various analytical processes, and instability can be observed [54,55].Therefore, these drawbacks opened great chances in the research area to prospect the use of green chemistry to improve environmental protection and to enhance the economics of chemical industries.The green chemistry notion shows an attractive technology to industrialists, scientists, researchers, and chemists for innovative chemistry, biology, and sensing applications.The perspective of plant extracts in the biogenic synthesis of nanomaterials such as metals and metal oxides involve the existence of bi-product metabolites, which act as reducing, stabilizing agents, or both.Furthermore, the same plant extract can be involved in the preparation of different types of nanomaterials; e.g., lemon extract has been utilized for the nanoengineering of noble metals and metal oxides [56,57].Many reports have described the green synthesis of nanomaterials [58][59][60] and their tremendous applications including, biosensors [61], catalysis [62], and biomedical studies [63].
Natural extracts such as Camellia sinensis (green tea) leaves and Origanum vulgare L. (wild oregano) leaf extracts were recommended in this study for the environmentally friendly preparation of ZnONPs and Al 2 O 3 NPs, respectively.The metal oxide nanoparticles were synthesized utilizing a simple green process with reactant (zinc sulfate and aluminum nitrate) precursors.This method offers various advantages, including simple preparation, precise temperature control of the reactant, ease of handling, and a one-step reaction.Different spectroscopic and microscopic approaches were used to comprehensively analyze the metal oxide nanomaterials that were obtained.The produced ZnONPs and Al 2 O 3 NPs nanoparticles were also utilized to determine the spectrofluorometric concentrations of two antibiotics, OFX and CPFX, in bulk powders and commercial formulations.

Apparatus
All spectrofluorometric detections were performed using a Shimadzu RF-5301pc luminescence spectrometer (Shimadzu, Kyoto, Japan) equipped with a 150W Xenon arc lamp, excitation grating, and emission monochromators.The excitation and emission monochromators were set at 5 nm slit width.The outcomes were automatically PC controlled and data acquisition was assessed by fluorescence intensity software, version 4.00.03.The spectrophotometric (UV-Vis) and Fourier transform infrared (FTIR) characterizations of the synthesized ZnONPs and Al 2 O 3 NPs were investigated using Ultrospec 2100-Biochrom spectrophotometer, (Biochrom Ltd., Cambium, Cambridge, UK) and a PerkinElmer FTIR spectrophotometer (Perki-nElmer Ltd., Yokohama, Japan), respectively.The surface morphologies of ZnONPs and Al 2 O 3 NPs were measured by JEM-2100F scanning electron microscope (JEOL Ltd., Tokyo, Japan) and JEM-1400 transmission electron microscope (JEOL Ltd., Tokyo, Japan).The elemental composition of ZnONPs and Al 2 O 3 NPs was studied at 20 kV using an Energy-dispersive X-ray (EDX, JSM-7610F; JEOL, Tokyo, Japan).The XRD patterns of the synthesized ZnONPs and Al 2 O 3 NPs were recorded by Siemens D-5000 diffractometer (Siemens, Erfurt, Germany).To adjust the pH conditions of the analytical solutions, Metrohm pH-meter model-744 (Metrohm Co., Herisau, Switzerland) was used.Deionized water obtained from Lonenaustauscher-SG, (Lonenaustauscher, Burgwedel, Germany) was used throughout the experimental studies.

Preparation of analytical solutions
Preparation of standard solutions of OFX and CPFX.Separate standard solutions (1000 μg mL −1 ) of each pure OFX and CPFX were prepared by dissolving 0.1 g in 100 mL of deionized water.The testing solutions were prepared in the concentration ranges of 1.0-300 and 10.0-400 ng mL −1 for the analysis of OFX and CPFX in the presence of ZnONPs.Others were prepared in the concentration ranges of 5-100 and 0.1-50 ng mL −1 for the determination of the same drugs in the presence of Al 2 O 3 NPs, respectively.
Preparation of eye drop and tablet samples.The standard solution of Oflox 1 0.3 w/v % eye-drop equivalent to 3 mg/mL of OFX was prepared by transferring 0.3 mL eye drop to a 100-mL volumetric flask and mixed with 50 mL of deionized water, followed by sonication for 20 min.The volume of the solution was adjusted up to the mark with deionized water to obtain a final concentration of 10 μg mL -1 of OFX.Ten tablets of Ciproxin 1 500 mg CPFX/tablet were weighed and finely powdered.An accurate amount (0.268 g) of the powder equivalent to 200 mg of CPFX was transferred into a small conical flask, in which 0.2 mol L -1 HCl was added to dissolve the powder.Then the solution was filtered and the residue was washed several times.The obtained solution was diluted to the desired concentration with deionized water.
Preparation of Camellia sinensis and Origanum vulgare L. leaves extract.Camellia sinensis leaves were collected and washed with deionized water, air-dried, and ground into fine powder.Approximately, 100 mL of deionized water was added to 5 g of Camellia sinensis powder and magnetically stirred for 2 h at 80˚C.The resulting extract was cooled to room temperature and filtered through Whatman filter paper No.1 [64].The obtained extract was then stored at 4˚C until employed for the preparation of ZnONPs for Origanum vulgare L. extract, approximately 500 g leaves were chopped into small pieces and macerated in 2.5 L of deionized water.The obtained mixture was refluxed for 4 h and the aqueous mixture was filtered, and then dried at 60˚C under vacuum using a rotary evaporator.A dark brownish color extract of 30 g was collected and stored at 4˚C [65].
Green synthesis of ZnONPs and Al 2 O 3 NPs.The green synthesis of ZnONPs was performed obeying the previously reported method [66] with sight modification.Briefly, For ZnONPs preparation, 30 mL of Camellia sinensis extract was mixed with 70 mL of zinc sulfate monohydrate (0.2 mol L -1 ) and stirred.Pale-white ZnONPs was formed and dries for 12 h at 60˚C.The product was calcined for 1 hour at 100˚C and stored for further expermints.Whereas slight modification of the procedure [67]  General analytical procedure.At room temperature, the fluorescence intensity for OFX and CPFX determination was examined in the presence of ZnONPs, Al 2 O 3 NPs, and SDS (1.0% w/v).The working solutions of the selected medications were examined using 10 mL volumetric flasks to estimate the pharmaceuticals in their pure samples and tablets.For OFX in the presence of ZnONPs and Al 2 O 3 NPs and SDS (1.0% w/v), and for CPFX in the presence of the same nanoparticles and SDS (1.0% w/v), the fluorescence detection was carried out at room temperature using λ em 480 nm and 470 nm after λ ex 294 nm, respectively.A regression equation was utilized to determine each of the tested drugs using the calibration graphs.The difference in the emission wavelengths can be attributed to the variation in the surface plasmon resonance of each compound in the presence of nanoparticles, and also the difference in ZnONPs and Al 2 O 3 NPs features of their crystalline phases.To the best of our knowledge that the strongest band gap the is shorter wavelength.The band gap of Al 2 O 3 NPs is higher than that of ZnONPs and hence the wavelength will shift towards less values than that in the presence of ZnONPs [68,69].

Characterization of ZnONPs and Al 2 O 3 NPs
The optical behavior of the prepared nanomaterials was investigated by applying UV-vis spectroscopy.Two broad absorption peaks were recorded at 220 and 300 nm for ZnSO 4 and another peak at 273 nm for Camellia sinensis leaves extract.A distinct peak due to the surface plasmon resonance (SPR) of ZnONPs was recorded at 347 nm (Fig 1A).The obtained spectra were in agreement with the literature [70].Furthermore, the absorption spectra in Fig 1B, revealed the appearance of two significant absorption peaks, which are corresponding to Origanum vulgare L. extract at 285 and 325 nm, and one peak at 238 nm corresponding to Al 2 O 3 NPs.The obtained spectra matched those in the literature [71].The formula Eg = hʋ was used to calculate the bandgap energy of the synthesized ZnONPs and Al 2 O 3 NPs, where Eg is the bandgap energy, h is a blank constant, and ʋ is the frequency.The calculated bandgaps were found as 3.57 and 5.21 eV for ZnONPs and Al 2 O 3 NPs, respectively.The red shift of absorption spectra of ZnONPs and the blue shift of Al 2 O 3 NPs were found to be at 347 and 238 nm, respectively, and the decrease of bandgap values indicated the presence of nanostructure materials.These different peaks, which have particle diameters between 50 and 100 nm, respectively, are thought to be the creation of ZnONPs and Al 2 O 3 NPs, according to the literature [66,67].The quantization effect is responsible for increasing the diameter of nanoparticles as the bandgap value decreases, although it never reaches zero [72].
The active functional groups or bonds of inorganic and organic compounds in the as-prepared ZnONPs were screened using FTIR spectroscopy.The observed peak in the region 417 cm −1 represents the formation of ZnO nanoparticles (Fig 1C).Various stretching vibration bands were recorded at 3431, 1581, and 1419 cm -1 related to O-H, C-O bonds, and N-H bonds for intercalated water and phytochemicals functional groups, respectively.These results matched the previously reported results for phytochemicals in plant extracts, which serve as capping and stabilizing materials on the surface of biosynthesized nanoparticles [70]

Optimization of experimental parameters
The experimental conditions of the suggested spectrofluorometric probes including, the effect of various parameters (type of solvent, volume of nanoparticles, type, and volume of surfactant, pH, detection time, and temperature) on the analytical estimation of the tested drugs were optimized.Table 1 summarized the optimized conditions of the suggested spectrofluorometric probes.
The suggested spectrofluorometric systems detected OFX and CPFX samples prepared in various solvents such as distilled water, methanol, ethanol, and acetonitrile.According to the nature of each solvent, the absorption maxima were recorded (Fig 6A).Dissolving the selected drugs (OFX and CPFX) in distilled water gave maximum fluorescence intensities in the The response time was also studied by performing the experimental analysis at various time intervals of 2-10 min to evaluate the reaction time between each drug sample and the added The influence of heat on the spectrofluorometric determination of OFX and CPFX was investigated by heating the samples and blank at 25-50˚C in a water bath.It was observed that raising the temperature by more than 25˚C reduced the fluorescence intensity of the two medicines.Therefore, the suggested spectrofluorometric systems for the determination of the OFX and CPFX were performed at ambient temperature (Fig 7B).The tested OFX and CPFX were found to exhibit weak emission bands at 470 and 425 nm after excitation wavelength at 294 and 275 nm, respectively.The addition of ZnONPs or Al 2 O 3 NPs to each fluorescence system,

Method validation
The suggested spectrofluorometric methods using ZnONPs and Al 2 O 3 NPs were validated using the previously recommended guidelines [78] to prove their accuracy and suitability for the determination of OFX and CPFX in their authentic samples.The calibration graphs of  both investigated drugs were constructed by plotting the fluorescence intensity vs. the increase in drug concentrations.Rectilinear relationships were obtained over the concentration ranges of 1.0-300 and 10.0-400 ng mL -1 for OFX and CPFX in the presence of SDS-ZnONPs, respectively, and 0.5-100 and 0.1-50 ng mL -1 for the same drugs in the presence of SDS-AL 2 O 3 NPs (Table 1).The created linear graph was revealed by statistical analysis of the data, which produced greater correlation coefficients (r) and lower intercept and slope standard deviations (S a and S b ), as shown in Table 2.The lower limits of detection (LOD) and quantification (LOQ) of the suggested spectrofluorometric methods were calculated.The LODs of the investigated OFX-SDS-ZnONPs and CPFX-SDS-Al 2 O 3 systems were (0.04 and 0.02 ng mL -1 ) and (0.03 and 0.04 ng mL -1 ) for the two probes, respectively.Using the ratio 3.3(Sa)/b, the LOD was calculated by determining the lowest level at which the analyte can be consistently identified.However, LOQ was quantified using the relation 10(S a )/b as the least quantity of analyte in a sample that can be acceptably detected with precision and accuracy values using the same optimized analytical conditions and was found to be (0.13 and 7.24 ng mL -1 ) and (0.1 and 0.09 ng mL -1 ) for the abovedescribed systems (Table 2).
To prove the accuracy of the suggested fluorescence systems, OFX and CPFX were determined in their authentic samples.The accuracy of the newly developed fluorescence probs was stated as estimated % recoveries 98.93 ± 0.84, 98.91 ± 0.91 in the presence of ZnONPs and 98.92 ± 0.88, 99.01 ± 0.60 for OFX and CPFX in the presence of Al 2 O 3 NPs, respectively (Table 3).
The precision of the suggested systems was evaluated using intra-day and inter-day assays.The relative standard deviation percentage (RSD%) was computed from the results of three duplicate tests using three analytical concentrations of OFX or CPFX (n = 3).The obtained mean RSD % was found to be 0.62%, 0.89% and 0.94%, 0.64% for intra-day assay of OFX, and CPFX in the presence of ZnONPs and Al 2 O 3 NPs, respectively.However, the inter-day assay showed mean RSD % of 0.58%, 0.8, % and 0.93%, 0.87% of the selected analyte in the presence of SDS-ZnONPs and SDS-Al 2 O 3 NPs, respectively.These results are <2%, indicating acceptable precision of the suggested systems.
The selectivity of the suggested spectrofluorometric systems for the quantification of OFX and CPFX in the presence of ZnONPs and Al 2 O 3 NPs was evaluated in the presence of various possible inactive ingredient species used as co-formulated materials in the production of tablets.Under the optimized conditions the tolerable level which was determined as the number of foreign species that produce an error of less than 5% was calculated using OFX and CPFX samples (1.0 ng mL -1 ).The obtained values of the selectivity levels proved that the suggested systems possess good selectivity for the determination of OFX and CPFX in the existence of SDS-ZnONPs or SDS-Al 2 O 3 NPs (Table 4).The robustness of the suggested approaches for the analysis of OFX and CPFX was evaluated by carrying out slight deviations in the analytical parameters.The robustness of the techniques was conducted by increasing or decreasing the pH value of (±1), varying the volume of SDS (±0.1 mL), the volume of ZnONPs (±0.2 mL) and the volume of Al 2 O 3 NPs (±0.1 mL).The fluorescence intensity was not exaggerated by these variations.The found % recoveries were 99.58 ± 0.82 and 99.05 ± 0.61 for OFX in the presence of SDS-ZnONPs and SDS-Al 2 O 3 NPs, respectively, and 98.25 ± 0.54 and 99.45 ± 1.30 for CPFX in the presence of SDS-ZnONPs and SDS-Al 2 O 3 NPs, respectively.
The ruggedness of the fluorescence determination probe for the detection and quantification of OFX and CPFX was investigated by estimating the same samples under different conditions, such as other analysts, laboratories, and devices.The fluorescence was not affected by these changes.The calculated % recoveries were (98.71 ± 1.21, 99.21 ± 0.74) and (98.45 ± 0.31, 99.74 ± 0.4) for OFX and CPFX in the presence of SDS-ZnONPs and SDS-Al 2 O 3 NPs, respectively.

Analytical applications
The proposed spectrofluorometric method was used to quantify OFX and CPFX in their pure powder (Table 5).
The obtained results were 99.50 ± 0.76 and 98.59 ± 0.66 for OFX and CPFX in the presence of SDS-ZnONPs.However, the mean percentage recoveries were 99.29 ± 0.97 and 99.42 ± 0.87 for the same drugs in the presence of SDS-Al 2 O 3 NPs, respectively.The obtained data indicated that the presence of metal oxide nanoparticles enhances the sensitivity of the suggested spectrofluorometric systems and this can be attributed to ZnONPs and Al 2 O 3 NPs possessing large surface areas and excellent optical properties.The suggested spectrofluorometric method was used to estimate OFX and CPFX in their commercial formulations (Oflox 1 0.3 w/v OFX eye drop and Ciproxin 1 500 mg CPFX/tablet) and the outcome data were presented in Table 6.The collected results were found to be 99.21 ± 0.69 and 100.26 ± 1.15 for OFX and CPFX in the presence of SDS-ZnONPs.The % recoveries were recorded as 99.25 ± 0.76 and 99.05 ± 0.72 for the same analytical samples in the existence of SDS-Al 2 O 2 NPs, respectively.Mathematical assessment for outcomes was performed using Student's t-test and variance ratio F-test [79] and the results were matched with those resulting from other published techniques [80,81].It was observed that the proposed spectrofluorometric systems exhibited excellent sensitivity for the determination of OFX and CPFX in the presence of SDS-ZnONPs and SDS-Al 2 O 3 NPs.These findings are explained by the enhancing effect of metal oxide on the collective oscillations of conduction electrons and localized surface plasmon resonances that strongly couple to light at particular wavelengths and give materials their exceptionally high optical characteristics.These metal oxide nanoparticles' high fluorescence activity was also a result of their large surface area, tunable features that developed during the synthesis of their nanostructures, and capacity to take up the oxygen groups of the drugs under study and improve their spectrofluorimetric determination.The outcomes also revealed that the addition of ZnONP for the detection of OFX and CPFX exhibited excellent sensitivity with wider concentration range than the addition of Al 2 O 3 NPs.This can be attributed to the high exciton binding energy of ZnO (~60 meV) would allow for excitonic transitions even at room temperature, which could mean high radiative recombination efficiency for spontaneous emission.However, in Al 2 O 3 NPs the exciton binding energy (~51.16meV) [82,83].
Furthermore, results from the suggested spectrofluorometric systems were compared to previously published analytical techniques such as spectrophotometric, fluorescence, electrochemical, and chromatographic approaches.The outcomes have been summarized in Table 7.
The suggested spectrofluorometric systems using metal oxide nanoparticles practically showed great sensitivity, cost advantages, simple manufacture, and environmental friendliness.They are also more accurate and precise and do not require high technical skills when compared to other chromatographic or electrochemical techniques.

Conclusion
This study described accurate and precise fluorescence probes based on metal oxide nanoparticles (ZnO and Al 2 O 3 ) for the quantification of antibiotics (OFX and CPFX) in their commercial dosage forms.The experimental detection was based on the extraordinary optical properties of ZnONPs and Al 2 O 3 NPs which enhance the fluorescence intestines of the selected drugs.The recorded data from the suggested fluorescence probes showed excellent catalytic activity of ZnONPs and Al 2 O 3 NPs and revealed that the increase in fluorescence was directly proportional to the increase in drug concentrations.The outcomes displayed excellent linearity over concentration ranges of 1.0-300, 10.0-400 ng mL -1 for OFX and CPFX in the presence was performed to synthesize Al 2 O 3 NPs.It was conducted by adding 10 mL of Origanum vulgare L. leaves extract to 40 mL of aluminum nitrate (2.0 mol L -1 ) and magnetically stirring for 25-30 min.A yellowish-brown Al 2 O 3 precipitate was formed.Then resulting Al 2 O 3 NPs were centrifuged and filtered using Whatman filter paper No 1, dried, and stored in a container for further experiments.Stock solutions of ZnONPs and Al 2 O 3 NPs were prepared by suspending 0.1 g of each nanopowder in 100 mL deionized water, then sonicated for 10 min and kept at 4˚C in the refrigerator.S1 Fig in S1 File represents the potential mechanism for green synthesis of ZnO and Al 2 O 3 NPs using plant extract.
. The FTIR spectrum (Fig 1D) of Al 2 O 3 NPs in the range of 500-4000 cm −1 showed two absorption peaks at 3466 and 1651 cm −1 representing the presence of stretching and bending O-H vibrations of the intermolecular layer of water, respectively.Broadband of Al-O vibration has appeared at 832 cm −1 .The noticed peak at 580 cm −1 represents the vibration of Al-O-Al [73].The particle size distribution of ZnONPs and Al 2 O 3 NPs was determined using the Zetasizer Ultra particle size analyzer (Malvern Panalytical Ltd, Malvern, UK).As demonstrated in Fig 2A and 2B, the particle size distributions were 94.25 nm and 114.8 nm for ZnONPs and Al 2 O 3 NPs, respectively.The obtained value confirmed that the green synthesized ZnO and Al 2 O 3 using Camellia sinensis and Origanum vulgare L. extracts are in nanoscale form.The zeta potential of green-synthesized ZnONPs and Al 2 O 3 NPs with negative values of about -15.9 and -23.5 mV indicated a strong negative charge (Fig 2C and 2D).The negative surface zeta potential of ZnONPs and Al 2 O 3 NPs suggests that the reduction process could be conducted through the surface-capped plant phytochemicals such as polyphenols compounds present in Camellia sinensis and Origanum vulgare L. extracts that were adsorbed on the surface of metal oxide nanoparticles.To study the crystal shape of the green synthesized ZnONPs and Al 2 O 3 NPs, X-ray diffraction patterns were detected over the 20-80˚2θ range.Fig 3A demonstrated sharp and distinct peaks, which revealed that the obtained metal oxide nanoparticles possess excellent

Fig 6 .
Fig 6.Optimization conditions: (a) Effect of solvents on the FI of OFX and CPFX dissolved in different solvents and in the absence of nanoparticles, (b) effect of type of surfactants (CPC, SDS and Triton x-100), (c) effect of volume of SDS and (d) effect of ZnONPs and Al 2 O 3 NPs volume.https://doi.org/10.1371/journal.pone.0286341.g006

Fig 7 .Fig 8 .
Fig 7. (a) Effect of time and (b) Effect of temperature on the fluorescence of OFX and CPFX determined in the presence of ZnONPs and Al 2 O 3 NPs.https://doi.org/10.1371/journal.pone.0286341.g007

Table 3 . Results of validation calculated from the determination of OFX and CPFX in bulk powder using the suggested spectrofluorometric systems in the presence of ZnONPs and Al 2 O 3 NPs, respectively.
https://doi.org/10.1371/journal.pone.0286341.t003

Table 6 . Assay of OFX, and CPFX in their commercial dosage forms applying the suggested spectrofluorometric systems in the presence of ZnONPs and Al 2 O 3 NPs, respectively.
ZnONPs and 0.5-100, 0.1-50 ng mL -1 in presence of SDS-Al 2 O 3 NPs, respectively.The estimated least square equations for the above-mentioned systems were FI = 1.951C + 192.27 (r = 0.9993), FI = 6.0164C + 185.64 (r = 0.9996), FI = 1.3885C + 286.83 (r = 0.9997) and FI = 16.039C+ 187.71 (r = 0.9995) in the presence of SDS-ZnONPs and SDS-Al 2 O 3 NPs, respectively.The proposed fluorescence probes were potentially used for the determination of OFX and CPFX in their commercial formulations with mean percentage recoveries of 99.21 ±0.69, 99.25±0.36,100.26±1.15 and 99.05±0.72 in the presence of ZnO and Al 2 O 3 nanoparticles, respectively.Statistical analysis of the resulting data was performed and the results were in good agreement with those reported from previously published methods.The suggested fluorescence methods, using the unique features of the synthesized ZnONPs and Al 2 O 3 NPs, revealed high catalytic activity and sensitivity due to the enhancement of surface plasmon resonance and collective oscillations of conduction electrons that coupled with light causing their strong optical features.